US stock futures flat after Wall St drops on Trump tariffs, soft jobs data
MINNEAPOLIS - OneMedNet Corporation (NASDAQ:ONMD) has secured approximately $3.7 million in gross proceeds through private placement transactions with accredited investors at $0.42 per share, the company announced Tuesday. The offering price represents a premium to the current trading price of $0.34, though the stock has declined 75% year-to-date according to InvestingPro data.
The medical imaging Real-World Data provider completed the private placements around June 19, with some of the company’s founders and directors participating in the transactions. The share price exceeded Nasdaq’s minimum price requirements.
OneMedNet plans to use the proceeds for working capital and general corporate purposes, according to the company statement.
During the second quarter of 2025, OneMedNet also took steps to strengthen its balance sheet, reducing its total liabilities by approximately 60% compared to March 31 figures. These improvements were crucial, as InvestingPro analysis shows the company’s Financial Health Score at a concerning 1.1 (WEAK), with short-term obligations exceeding liquid assets. These actions included:
- Settling approximately $3.26 million in deferred underwriter fees
- Settling approximately $1.08 million in additional trade payables
- Converting approximately $6.56 million of principal and interest into common stock
- Redeeming the remaining $250,000 of a convertible promissory note issued to Yorkville Advisors Global
In total, these measures settled or converted about $11 million of the company’s current liabilities.
The securities sold in the private placement have not been registered under the Securities Act of 1933 and were offered in transactions not involving a public offering. OneMedNet has agreed to register these shares with the SEC. InvestingPro subscribers can access 8 additional key financial tips and comprehensive metrics about OneMedNet’s financial health and valuation status.
OneMedNet operates a platform that provides de-identified medical imaging and electronic health records from over 1,400 healthcare sites. With a market capitalization of $10.39 million, the company faces significant challenges, including negative gross profit margins and rapid cash burn. The information is based on a company press release and InvestingPro data.
In other recent news, OneMedNet Corporation has been notified by The Nasdaq Stock Market LLC that its stock does not meet the minimum bid price requirement, as stated in a recent 8-K filing with the U.S. Securities and Exchange Commission. The company’s common stock has closed below the $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq’s Listing Rule 5550(a)(2). This notification triggers a 180-day period, ending on October 7, 2025, for OneMedNet to regain compliance by maintaining a minimum bid price of $1.00 or more for at least ten consecutive business days. If the company fails to meet this requirement, it may be granted an additional 180 days to comply, provided it meets all other initial listing standards for The Nasdaq Capital Market, except for the bid price. OneMedNet is considering options such as a potential reverse stock split to address the deficiency. The company is actively monitoring its stock’s bid price and intends to take necessary actions to achieve compliance. Investors are closely watching this situation, as failure to regain compliance could lead to delisting, affecting the stock’s marketability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.